• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评价肾移植受者中新型 DSA 发展与 CXCR5+PD-1+CD8+T 细胞和 PD-1/PD-L1mRNA 表达之间的关系。

Evaluation of the relationship between de-novo DSA development and CXCR5+PD-1+CD8+ T cells and PD-1/PD-L1 mRNA expression in kidney transplant recipients.

机构信息

Department of Medical Biology and Genetics, Akdeniz University Faculty of Medicine, Antalya, Turkey.

Division of Nephrology, Department of Internal Medicine, Akdeniz University Faculty of Medicine, Antalya, Turkey.

出版信息

Clin Transplant. 2023 Nov;37(11):e15104. doi: 10.1111/ctr.15104. Epub 2023 Aug 17.

DOI:10.1111/ctr.15104
PMID:37589946
Abstract

BACKGROUND AND AIMS

The relationship between the Follicular Cytotoxic T cell subgroup and expression levels of PD1/PD-L1 genes and the development of donor specific antibody (DSA) is unknown. In this study, we aimed to examine CD8+CXCR5+PD-1+ follicular cytotoxic T cell levels and expression levels of PD1/PD-L1 genes in peripheral blood lymphocytes in de-novo DSA positive and negative kidney transplant recipients (KTR).

METHODS

In our study, expression of PD-1/ PD-L1 genes by Real-Time Quantitative PCR method and CD8+CXCR5+PD-1+ T cell expression levels by flow cytometric method were obtained from peripheral blood samples. 63 participants were included in the study (de-novo DSA positive recipients (n = 22, group 1), de-novo DSA negative recipients (n = 20, group 2) and healthy control (n = 21, group 3). All patients had negative PRA before kidney transplantation. Expression (%) levels of target cells were evaluated by flow cytometry method. IBM SPSS Statistics for Windows Version 22 and R.3.3.2 software were used to evaluate the data.

RESULTS

The demographic data of the groups were similar. PD-1 mRNA expression was higher in de-novo DSA positive KTR than negative (respectively, 1.03 ± .29/.82 ± .15, p: .001). CD8+CXCR5+PD-1+ T cell expression levels were found to be higher in the de-novo DSA positive group than in the negative group and similar to the healthy group (respectively, 3.06 ± 1.98/.52 ± .40, p:.001, 3.06 ± 1.98/2.78 ± .59, p:.62). The percentage of CD8+CXCR5+PD-1+ expressing T cells was significantly lower in the HLA-Class II+ group than other groups (HLA CI/II/ I+II, respectively, 3.63 ± 2.72/1.65 ± .50/3.68 ± 1.67, p: .04).

CONCLUSIONS

In our study, a significant relationship was found between DSA formation and PD-1 mRNA level and CD8+CXCR5+PD-1+ follicular cytotoxic T cell in KTR.

摘要

背景与目的

滤泡细胞毒性 T 细胞亚群与 PD1/PD-L1 基因的表达水平以及供体特异性抗体(DSA)的发展之间的关系尚不清楚。本研究旨在检测初发 DSA 阳性和阴性肾移植受者(KTR)外周血淋巴细胞中 CD8+CXCR5+PD-1+滤泡细胞毒性 T 细胞水平和 PD1/PD-L1 基因的表达水平。

方法

本研究通过实时定量 PCR 方法检测 PD-1/PD-L1 基因的表达,通过流式细胞术检测 CD8+CXCR5+PD-1+T 细胞的表达水平。共纳入 63 例患者(初发 DSA 阳性受者(n=22,第 1 组)、初发 DSA 阴性受者(n=20,第 2 组)和健康对照组(n=21,第 3 组)。所有患者在肾移植前 PRA 均为阴性。通过流式细胞术评估靶细胞的表达(%)水平。采用 IBM SPSS Statistics for Windows Version 22 和 R.3.3.2 软件对数据进行评估。

结果

各组的人口统计学数据相似。与阴性组相比,初发 DSA 阳性 KTR 的 PD-1mRNA 表达更高(分别为 1.03±0.29/0.82±0.15,p:0.001)。初发 DSA 阳性组的 CD8+CXCR5+PD-1+T 细胞表达水平高于阴性组,与健康组相似(分别为 3.06±1.98/0.52±0.40,p:0.001,3.06±1.98/2.78±0.59,p:0.62)。与其他组相比,HLA-Class II+组的 CD8+CXCR5+PD-1+表达 T 细胞的百分比明显更低(HLA CI/II/ I+II,分别为 3.63±2.72/1.65±0.50/3.68±1.67,p:0.04)。

结论

在本研究中,我们发现 KTR 中 DSA 形成与 PD-1mRNA 水平和 CD8+CXCR5+PD-1+滤泡细胞毒性 T 细胞之间存在显著关系。

相似文献

1
Evaluation of the relationship between de-novo DSA development and CXCR5+PD-1+CD8+ T cells and PD-1/PD-L1 mRNA expression in kidney transplant recipients.评价肾移植受者中新型 DSA 发展与 CXCR5+PD-1+CD8+T 细胞和 PD-1/PD-L1mRNA 表达之间的关系。
Clin Transplant. 2023 Nov;37(11):e15104. doi: 10.1111/ctr.15104. Epub 2023 Aug 17.
2
CXCR5PD1ICOS Circulating T Follicular Helpers Are Associated With Donor-Specific Antibodies After Renal Transplantation.CXCR5+PD-1+ICOS+ 滤泡辅助性 T 细胞与肾移植后供体特异性抗体相关。
Front Immunol. 2019 Sep 10;10:2071. doi: 10.3389/fimmu.2019.02071. eCollection 2019.
3
Inverse Association Between the Quantity of Human Peripheral Blood CXCR5+IFN-γ+CD8+ T Cells With De Novo DSA Production in the First Year After Kidney Transplant.在肾移植后第一年,人外周血 CXCR5+IFN-γ+CD8+T 细胞数量与新产生的 DSA 呈负相关。
Transplantation. 2020 Nov;104(11):2424-2434. doi: 10.1097/TP.0000000000003151.
4
The diagnostic role of PD-1 CXCR5 follicular helper CD8 T cell in renal allograft dysfunction.PD-1+CXCR5+滤泡辅助性 CD8 T 细胞在移植肾失功中的诊断作用
J Clin Lab Anal. 2022 Feb;36(2):e24200. doi: 10.1002/jcla.24200. Epub 2021 Dec 26.
5
Follicular helper T cells promote the effector functions of CD8 T cells via the provision of IL-21, which is downregulated due to PD-1/PD-L1-mediated suppression in colorectal cancer.滤泡辅助 T 细胞通过提供 IL-21 来促进 CD8 T 细胞的效应功能,而在结直肠癌中,由于 PD-1/PD-L1 介导的抑制作用,IL-21 的表达下调。
Exp Cell Res. 2018 Nov 1;372(1):35-42. doi: 10.1016/j.yexcr.2018.09.006. Epub 2018 Sep 8.
6
Follicular CD8+ T Cells Are Elevated in HIV Infection and Induce PD-L1 on B Cells.滤泡性 CD8+ T 细胞在 HIV 感染中升高,并诱导 B 细胞表达 PD-L1。
J Immunol. 2023 Jan 1;210(1):33-39. doi: 10.4049/jimmunol.2200194.
7
Clinical significance of low pre-transplant donor specific antibodies (DSA) in living donor kidney recipients with negative complement-dependent cytotoxicity crossmatches (CDCXM), and negative flow cytometry crossmatches (FLXM) - A single-center experience.移植前低供体特异性抗体(DSA)在阴性补体依赖性细胞毒性交叉匹配(CDCXM)和阴性流式细胞术交叉匹配(FLXM)的活体供肾受者中的临床意义 - 单中心经验。
Transpl Immunol. 2022 Oct;74:101672. doi: 10.1016/j.trim.2022.101672. Epub 2022 Jul 19.
8
Pretransplant angiotensin II type 1-receptor antibodies are a risk factor for earlier detection of de novo HLA donor-specific antibodies.移植前血管紧张素 II 型 1 型受体抗体是早期检测新 HLA 供体特异性抗体的一个危险因素。
Nephrol Dial Transplant. 2016 Oct;31(10):1738-45. doi: 10.1093/ndt/gfw204. Epub 2016 May 24.
9
Basiliximab is associated with a lower incidence of De novo donor-specific HLA antibodies in kidney transplant recipients: A single-center experience.巴利昔单抗与肾移植受者中新发供者特异性 HLA 抗体的较低发生率相关:一项单中心经验。
Transpl Immunol. 2023 Apr;77:101778. doi: 10.1016/j.trim.2022.101778. Epub 2022 Dec 28.
10
Immunologic outcome in elderly kidney transplant recipients: is it time for HLA-DR matching?老年肾移植受者的免疫结局:是否到了 HLA-DR 匹配的时候?
Nephrol Dial Transplant. 2016 Dec;31(12):2143-2149. doi: 10.1093/ndt/gfw248. Epub 2016 Jul 1.